| Literature DB >> 28108094 |
Bénilde Bonnefille1, Lauren Arpin-Pont1, Elena Gomez1, Hélène Fenet1, Frédérique Courant2.
Abstract
Despite the growing concern on the presence of pharmaceutically active compounds in the environment, few studies have been conducted on their metabolism in marine organisms. In this study, a non-targeted strategy based on the generation of chemical profiles generated by liquid chromatography combined with high resolution mass spectrometry was used to highlight metabolite production by the Mediterranean mussel (Mytilus galloprovincialis) after diclofenac exposure. This method allowed revealing the production of 13 metabolites in mussel tissues. Three of them were phase I metabolites, including 4'-hydroxy-diclofenac and 5-hydroxy-diclofenac. The remaining 10 were phase II metabolites, including sulfate and amino acids conjugates. Among all of the metabolites highlighted, 5 were reported for the first time in an aquatic organism exposed to diclofenac.Entities:
Keywords: Aquatic organism; LC-HRMS; Metabolism; NSAID; Non-targeted strategy
Mesh:
Substances:
Year: 2017 PMID: 28108094 DOI: 10.1016/j.scitotenv.2017.01.063
Source DB: PubMed Journal: Sci Total Environ ISSN: 0048-9697 Impact factor: 7.963